New studies find no safety concerns with benzoyl peroxide in acne products, addressing earlier controversy about high levels of benzene.
- Two new studies on benzoyl peroxide (BP)–containing acne products found no concern about high blood levels of benzene or cancer risk.
- Controversy arose earlier this year after Valisure petitioned the FDA to recall BP products due to high benzene levels, but the new studies provide reassurance about product safety.
- The studies, published in the Journal of the American Academy of Dermatology, found no difference in blood benzene levels between BP product users and non-users.
- A larger study of over 27,000 patients using BP products showed no increased risk for cancer, including blood cancers and solid tumors.
- Despite the reassuring findings, precautions such as avoiding high temperatures for product storage and discarding old products are recommended.
Source link
Dermatology,Dermatology,Pharmacists,Public Health & Prevention